Literature DB >> 15027751

Study of enteropathogenic Escherichia coli(EPEC) diarrhoea in children.

Reeta Mani1, Usha Udgaonkar, Susheela Pawar.   

Abstract

Enteropathogenic E. coli (EPEC) are one of the predominant aetiological agents of diarrhoea in children. A study was undertaken to determine the incidence of EPEC diarrhoea in children and to assess the clinical spectrum. Faecal samples from 300 children below 12 years of age, hospitalised with acute diarrhoea were processed for isolation of bacterial pathogens. EPEC were isolated from 36(12%) of the diarrhoeal cases. O86 was the predominant serogroup isolated. EPEC diarrhoea was common in children below two years of age (86.1%). Vomiting, fever and dehydration were the common presenting features. Faecalleucocytes were observed in 17(47.2%)stool samples. EPEC were found to be resistant to several antibiotics. Since EPEC are known to belong to restricted number of 'O' sergroups, serogrouping with 'O' antisera to predominant EPEC serogroups in a particular area remains the most convenient method for early detection of EPEC diarrhoea in children.

Entities:  

Mesh:

Year:  2003        PMID: 15027751

Source DB:  PubMed          Journal:  Indian J Pathol Microbiol        ISSN: 0377-4929            Impact factor:   0.740


  3 in total

1.  Serotypes, intimin subtypes, and antimicrobial resistance patterns of atypical enteropathogenic Escherichia coli isolated in England from 1993 to 1996.

Authors:  C Jenkins; H R Smith; A J Lawson; G A Willshaw; T Cheasty; J G Wheeler; D S Tompkins
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-01       Impact factor: 3.267

2.  Modulation of acute diarrheal illness by persistent bacterial infection.

Authors:  Megan E McBee; Patricia Z Zheng; Arlin B Rogers; James G Fox; David B Schauer
Journal:  Infect Immun       Date:  2008-08-18       Impact factor: 3.441

3.  ABO Antigens Active Tri- and Disaccharides Microarray to Evaluate C-type Lectin Receptor Binding Preferences.

Authors:  Chethan D Shanthamurthy; Prashant Jain; Sharon Yehuda; João T Monteiro; Shani Leviatan Ben-Arye; Balamurugan Subramani; Bernd Lepenies; Vered Padler-Karavani; Raghavendra Kikkeri
Journal:  Sci Rep       Date:  2018-04-26       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.